{"transactions":[{"id":195642,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2012-02-16T20:00:25.000Z","date":"2011-12-29","kind":"gift","acquired":false,"shares":20,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":51186,"source":{"system":"sec-edgar","filing":"0001209191-12-010739","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112010739/doc5.xml","form_type":"5"}},{"id":195641,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2012-02-16T20:00:25.000Z","date":"2011-12-20","kind":"gift","acquired":false,"shares":20,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":51206,"source":{"system":"sec-edgar","filing":"0001209191-12-010739","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112010739/doc5.xml","form_type":"5"}},{"id":195640,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2012-02-16T20:00:25.000Z","date":"2011-12-16","kind":"gift","acquired":false,"shares":40,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":51226,"source":{"system":"sec-edgar","filing":"0001209191-12-010739","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112010739/doc5.xml","form_type":"5"}},{"id":196148,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Restricted Stock Unit","published_at":"2012-02-02T20:43:00.000Z","date":"2012-02-01","kind":"exercise","acquired":false,"shares":87924,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2012-02-01","expiration_date":"2012-02-01","underlying":"Common Stock","underlying_shares":87924},"source":{"system":"sec-edgar","filing":"0001209191-12-006939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112006939/doc4.xml","form_type":"4"}},{"id":196147,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2012-02-02T20:43:00.000Z","date":"2012-02-01","kind":"tax_withholding","acquired":false,"shares":36463,"price":39.74,"value":1449039.62,"ownership":{"direct":true},"balance_after":102647,"source":{"system":"sec-edgar","filing":"0001209191-12-006939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112006939/doc4.xml","form_type":"4"}},{"id":196146,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2012-02-02T20:43:00.000Z","date":"2012-02-01","kind":"exercise","acquired":true,"shares":87924,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":139110,"source":{"system":"sec-edgar","filing":"0001209191-12-006939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112006939/doc4.xml","form_type":"4"}},{"id":197544,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-12-14T16:21:09.000Z","date":"2011-12-12","kind":"sale","acquired":false,"shares":5787,"price":39.1,"value":226271.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $39.06 to $39.15.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":51266,"source":{"system":"sec-edgar","filing":"0001209191-11-061194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111061194/doc4.xml","form_type":"4"}},{"id":198094,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-11-14T17:08:57.000Z","date":"2011-11-11","kind":"sale","acquired":false,"shares":5700,"price":37.55,"value":214035.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011."}],"balance_after":57053,"source":{"system":"sec-edgar","filing":"0001209191-11-055635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111055635/doc4.xml","form_type":"4"}},{"id":198871,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-10-13T15:36:03.000Z","date":"2011-10-11","kind":"sale","acquired":false,"shares":5700,"price":38.1,"value":217170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $38.05 to $38.19.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":62753,"source":{"system":"sec-edgar","filing":"0001209191-11-051643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111051643/doc4.xml","form_type":"4"}},{"id":199453,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-09-14T14:45:34.000Z","date":"2011-09-12","kind":"sale","acquired":false,"shares":5700,"price":35.91,"value":204687.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011."}],"balance_after":68453,"source":{"system":"sec-edgar","filing":"0001209191-11-047782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111047782/doc4.xml","form_type":"4"}},{"id":199452,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-09-14T14:45:34.000Z","date":"2011-08-26","kind":"gift","acquired":false,"shares":145,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":74153,"source":{"system":"sec-edgar","filing":"0001209191-11-047782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111047782/doc4.xml","form_type":"4"}},{"id":200087,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-08-12T18:47:18.000Z","date":"2011-08-11","kind":"sale","acquired":false,"shares":5700,"price":33.94,"value":193458.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $33.90 to $34.00.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":74298,"source":{"system":"sec-edgar","filing":"0001209191-11-043960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111043960/doc4.xml","form_type":"4"}},{"id":200802,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-07-13T18:36:48.000Z","date":"2011-07-11","kind":"sale","acquired":false,"shares":5700,"price":37.39,"value":213123.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $37.35 to $37.40.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":79998,"source":{"system":"sec-edgar","filing":"0001209191-11-039364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111039364/doc4.xml","form_type":"4"}},{"id":200801,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-07-13T18:36:48.000Z","date":"2011-07-01","kind":"gift","acquired":false,"shares":554,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":85698,"source":{"system":"sec-edgar","filing":"0001209191-11-039364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111039364/doc4.xml","form_type":"4"}},{"id":200800,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-07-13T18:36:48.000Z","date":"2011-06-28","kind":"gift","acquired":false,"shares":55,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":86252,"source":{"system":"sec-edgar","filing":"0001209191-11-039364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111039364/doc4.xml","form_type":"4"}},{"id":201393,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-06-15T13:45:00.000Z","date":"2011-06-13","kind":"sale","acquired":false,"shares":5700,"price":37.25,"value":212325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $37.20 to $37.29.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":86307,"source":{"system":"sec-edgar","filing":"0001209191-11-034699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111034699/doc4.xml","form_type":"4"}},{"id":202134,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-05-13T13:15:10.000Z","date":"2011-05-11","kind":"sale","acquired":false,"shares":5700,"price":38.21,"value":217797.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $38.18 to $38.27.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":92007,"source":{"system":"sec-edgar","filing":"0001209191-11-028166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111028166/doc4.xml","form_type":"4"}},{"id":204060,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-04-12T19:30:42.000Z","date":"2011-04-11","kind":"sale","acquired":false,"shares":5700,"price":35.76,"value":203832.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $35.73 to $35.81.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":97707,"source":{"system":"sec-edgar","filing":"0001209191-11-022593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111022593/doc4.xml","form_type":"4"}},{"id":207093,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-02-17T21:34:07.000Z","date":"2011-02-16","kind":"sale","acquired":false,"shares":3100,"price":34.49,"value":106919.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010."}],"balance_after":103407,"source":{"system":"sec-edgar","filing":"0001209191-11-010612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111010612/doc4.xml","form_type":"4"}},{"id":207618,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Restricted Stock Unit","published_at":"2011-02-03T22:56:28.000Z","date":"2011-02-01","kind":"exercise","acquired":false,"shares":82942,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2011-02-01","expiration_date":"2011-02-01","underlying":"Common Stock","underlying_shares":82942},"source":{"system":"sec-edgar","filing":"0001209191-11-006873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111006873/doc4.xml","form_type":"4"}},{"id":207617,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-02-03T22:56:28.000Z","date":"2011-02-01","kind":"tax_withholding","acquired":false,"shares":31555,"price":34.77,"value":1097167.35,"ownership":{"direct":true},"balance_after":106507,"source":{"system":"sec-edgar","filing":"0001209191-11-006873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111006873/doc4.xml","form_type":"4"}},{"id":207616,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-02-03T22:56:28.000Z","date":"2011-02-01","kind":"exercise","acquired":true,"shares":82942,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":138062,"source":{"system":"sec-edgar","filing":"0001209191-11-006873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111006873/doc4.xml","form_type":"4"}},{"id":207918,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-01-31T14:55:53.000Z","date":"2010-06-21","kind":"gift","acquired":false,"shares":1160,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":73930,"source":{"system":"sec-edgar","filing":"0001209191-11-005644","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111005644/doc5.xml","form_type":"5"}},{"id":207917,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-01-31T14:55:53.000Z","date":"2010-05-03","kind":"gift","acquired":false,"shares":145,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75090,"source":{"system":"sec-edgar","filing":"0001209191-11-005644","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111005644/doc5.xml","form_type":"5"}},{"id":207916,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-01-31T14:55:53.000Z","date":"2010-04-28","kind":"gift","acquired":false,"shares":175,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75235,"source":{"system":"sec-edgar","filing":"0001209191-11-005644","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111005644/doc5.xml","form_type":"5"}},{"id":207915,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-01-31T14:55:53.000Z","date":"2010-03-22","kind":"gift","acquired":false,"shares":330,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75410,"source":{"system":"sec-edgar","filing":"0001209191-11-005644","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111005644/doc5.xml","form_type":"5"}},{"id":208052,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Restricted Stock Unit","published_at":"2011-01-27T23:11:32.000Z","date":"2011-01-25","kind":"grant","acquired":true,"shares":87924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":87924,"derivative":{"exercise_date":"2012-02-01","expiration_date":"2012-02-01","underlying":"Common Stock","underlying_shares":87924},"source":{"system":"sec-edgar","filing":"0001209191-11-005340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111005340/doc4.xml","form_type":"4"}},{"id":208462,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2011-01-18T18:24:54.000Z","date":"2011-01-14","kind":"sale","acquired":false,"shares":3100,"price":34.87,"value":108097.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010."}],"balance_after":56930,"source":{"system":"sec-edgar","filing":"0001209191-11-003397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111003397/doc4.xml","form_type":"4"}},{"id":209007,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2010-12-17T20:54:31.000Z","date":"2010-12-16","kind":"sale","acquired":false,"shares":3100,"price":35.1,"value":108810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010."}],"balance_after":60030,"source":{"system":"sec-edgar","filing":"0001209191-10-061374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110061374/doc4.xml","form_type":"4"}},{"id":209006,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2010-12-17T20:54:31.000Z","date":"2010-12-09","kind":"gift","acquired":false,"shares":105,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63130,"source":{"system":"sec-edgar","filing":"0001209191-10-061374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110061374/doc4.xml","form_type":"4"}},{"id":209005,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2010-12-17T20:54:31.000Z","date":"2010-12-07","kind":"gift","acquired":false,"shares":60,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63235,"source":{"system":"sec-edgar","filing":"0001209191-10-061374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110061374/doc4.xml","form_type":"4"}},{"id":209004,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2010-12-17T20:54:31.000Z","date":"2010-12-06","kind":"gift","acquired":false,"shares":45,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63295,"source":{"system":"sec-edgar","filing":"0001209191-10-061374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110061374/doc4.xml","form_type":"4"}},{"id":209615,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2010-11-17T19:10:07.000Z","date":"2010-11-16","kind":"sale","acquired":false,"shares":3100,"price":34.43,"value":106733.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010."}],"balance_after":63340,"source":{"system":"sec-edgar","filing":"0001209191-10-055440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110055440/doc4.xml","form_type":"4"}},{"id":210879,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2010-10-19T17:16:48.000Z","date":"2010-10-15","kind":"sale","acquired":false,"shares":3100,"price":37.65,"value":116715.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010."}],"balance_after":66440,"source":{"system":"sec-edgar","filing":"0001209191-10-050849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110050849/doc4.xml","form_type":"4"}},{"id":211716,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2010-09-17T19:16:11.000Z","date":"2010-09-16","kind":"sale","acquired":false,"shares":3100,"price":35.55,"value":110205.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010."}],"balance_after":69540,"source":{"system":"sec-edgar","filing":"0001209191-10-046772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110046772/doc4.xml","form_type":"4"}},{"id":212144,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2010-08-18T16:32:25.000Z","date":"2010-08-16","kind":"sale","acquired":false,"shares":3100,"price":35.33,"value":109523.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010."}],"balance_after":72640,"source":{"system":"sec-edgar","filing":"0001209191-10-043118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110043118/doc4.xml","form_type":"4"}},{"id":217029,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Est Markets BU"}}],"security":"Common Stock","published_at":"2010-02-03T17:07:44.000Z","date":"2009-12-22","kind":"gift","acquired":false,"shares":244,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38035,"source":{"system":"sec-edgar","filing":"0001209191-10-006386","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110006386/doc5.xml","form_type":"5"}},{"id":217028,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Est Markets BU"}}],"security":"Common Stock","published_at":"2010-02-03T17:07:44.000Z","date":"2009-06-22","kind":"gift","acquired":false,"shares":630,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38279,"source":{"system":"sec-edgar","filing":"0001209191-10-006386","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110006386/doc5.xml","form_type":"5"}},{"id":217027,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Est Markets BU"}}],"security":"Common Stock","published_at":"2010-02-03T17:07:44.000Z","date":"2009-03-13","kind":"gift","acquired":false,"shares":630,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38909,"source":{"system":"sec-edgar","filing":"0001209191-10-006386","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110006386/doc5.xml","form_type":"5"}},{"id":217047,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Est Markets BU"}}],"security":"Restricted Stock Unit","published_at":"2010-02-03T16:06:44.000Z","date":"2010-02-01","kind":"exercise","acquired":false,"shares":51249,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2010-02-01","expiration_date":"2010-02-01","underlying":"Common Stock","underlying_shares":51249},"source":{"system":"sec-edgar","filing":"0001209191-10-006352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110006352/doc4.xml","form_type":"4"}},{"id":217046,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Est Markets BU"}}],"security":"Common Stock","published_at":"2010-02-03T16:06:44.000Z","date":"2010-02-01","kind":"tax_withholding","acquired":false,"shares":17669,"price":35.2,"value":621948.8,"ownership":{"direct":true},"balance_after":75740,"source":{"system":"sec-edgar","filing":"0001209191-10-006352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110006352/doc4.xml","form_type":"4"}},{"id":217045,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Est Markets BU"}}],"security":"Common Stock","published_at":"2010-02-03T16:06:44.000Z","date":"2010-02-01","kind":"exercise","acquired":true,"shares":51249,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":93409,"source":{"system":"sec-edgar","filing":"0001209191-10-006352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110006352/doc4.xml","form_type":"4"}},{"id":217268,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Est Markets BU"}}],"security":"Restricted Stock Unit","published_at":"2010-01-28T23:03:26.000Z","date":"2010-01-26","kind":"grant","acquired":true,"shares":82942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":82942,"derivative":{"exercise_date":"2011-02-01","expiration_date":"2011-02-01","underlying":"Common Stock","underlying_shares":82942},"source":{"system":"sec-edgar","filing":"0001209191-10-005333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110005333/doc4.xml","form_type":"4"}},{"id":217267,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Pres, Est Markets BU"}}],"security":"Common Stock","published_at":"2010-01-28T23:03:26.000Z","date":"2010-01-26","kind":"grant","acquired":true,"shares":4125,"price":36.16,"value":149160.0,"ownership":{"direct":true},"balance_after":42160,"source":{"system":"sec-edgar","filing":"0001209191-10-005333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110005333/doc4.xml","form_type":"4"}},{"id":226562,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Marketing & Sales"}}],"security":"Common Stock","published_at":"2009-02-12T16:25:29.000Z","date":"2008-12-08","kind":"gift","acquired":false,"shares":75,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39631,"source":{"system":"sec-edgar","filing":"0001209191-09-008373","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919109008373/doc5.xml","form_type":"5"}},{"id":226561,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Marketing & Sales"}}],"security":"Common Stock","published_at":"2009-02-12T16:25:29.000Z","date":"2008-12-08","kind":"gift","acquired":false,"shares":60,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39706,"source":{"system":"sec-edgar","filing":"0001209191-09-008373","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919109008373/doc5.xml","form_type":"5"}},{"id":226560,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Marketing & Sales"}}],"security":"Common Stock","published_at":"2009-02-12T16:25:29.000Z","date":"2008-12-08","kind":"gift","acquired":false,"shares":150,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39766,"source":{"system":"sec-edgar","filing":"0001209191-09-008373","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919109008373/doc5.xml","form_type":"5"}},{"id":226559,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Marketing & Sales"}}],"security":"Common Stock","published_at":"2009-02-12T16:25:29.000Z","date":"2008-06-17","kind":"gift","acquired":false,"shares":312,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39916,"source":{"system":"sec-edgar","filing":"0001209191-09-008373","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919109008373/doc5.xml","form_type":"5"}},{"id":227104,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12937,"kind":"person","name":"Carmine Bryce D.","position":1,"cik":"0001430788","reported_name":"Carmine Bryce D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Marketing & Sales"}}],"security":"Restricted Stock Unit","published_at":"2009-01-29T22:34:41.000Z","date":"2009-01-27","kind":"grant","acquired":true,"shares":51249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":51249,"derivative":{"exercise_date":"2010-02-01","expiration_date":"2010-02-01","underlying":"Common Stock","underlying_shares":51249},"source":{"system":"sec-edgar","filing":"0001209191-09-005395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919109005395/doc4.xml","form_type":"4"}}]}